Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

m/s. aspiro pharma limited - remdesivir - powder lyophilized for solution for infusion - 100mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

gilead sciences ltd - remdesivir - powder for solution for infusion - 100mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

gilead sciences ltd - remdesivir - powder for solution for infusion - 150mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

gilead sciences ltd - remdesivir - solution for infusion - 5mg/1ml

Singapore - English - HSA (Health Sciences Authority)

gilead sciences singapore pte. ltd. - remdesivir - injection, powder, lyophilized, for solution - remdesivir 100mg

Canada - English - Health Canada

gilead sciences canada inc - remdesivir - solution - 100mg - remdesivir 100mg - nucleosides and nucleotides

Canada - English - Health Canada

gilead sciences canada inc - remdesivir - powder for solution - 100mg - remdesivir 100mg - nucleosides and nucleotides

European Union - English - EMA (European Medicines Agency)

gilead sciences ireland uc - remdesivir - covid-19 virus infection - veklury is indicated for the treatment of coronavirus disease 2019 (covid 19) in:adults and paediatric patients (at least 4 weeks of age and weighing at least 3 kg) with pneumonia requiring supplemental oxygen (low- or high-flow oxygen or other non-invasive ventilation at start of treatment)adults and paediatric patients (weighing at least 40 kg) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19

Israel - English - Ministry of Health

gilead sciences israel ltd - remdesivir - powder for concentrate for solution for infusion - remdesivir 100 mg/vial - veklury is indicated for the treatment of coronavirus disease 2019 (covid-19) -in adults and pediatric patients (at least 4 weeks of age and weighing at least 3 kg) with pneumonia requiring supplemental oxygen (low- or high-flow oxygen or other non-invasive ventilation at start of treatment).-adults who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

mylan pharmaceuticals (pty) ltd - powder - 100,0 mg - each vial contains remdesivir 100,0 mg